Company Performance Metrics
- Boris Zaslavsky: Chief Scientific Officer
Bob Rochelle: Chief Commercial OfficerPast Role: Good Start Genetics, VP, Strategic Marketing & Global Commercial Development
Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. Its solvent interaction analysis technology investigates protein biomarkers at the structural level, providing better and more direct insights regarding the
protein origin on the cellular level, thus improving test specificity to the underlying disease process. Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases.